Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03707067
Other study ID # SMU_SHAS_2018_02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2018
Est. completion date February 28, 2019

Study information

Verified date October 2018
Source St Mary's University College
Contact Freddy Brown, PhD
Phone 07746075161
Email freddybrown1984@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aims To assess the efficacy of made to measure, high pressure compression garments (CG) for facilitating the recovery of strength, muscular power, and physiological markers of muscle damage following fencing, when compared a sham treatment

Rationale for study design

The results of a recent meta-analysis have informed the design of this study. The conclusions of the meta-analysis were that CG are most effective for the recovery of:

- Force and power performance following eccentric/plyometric exercise

- Maximal force production, at least 24 hours post-exercise (for example in strength and power athletes undertaking resistance training programmes)

- Additionally, the recovery of high-intensity cardiovascular performance may also be enhanced by the used of CG, when tested 24 hours following exercise which incurs metabolic stress Accordingly, the current study was designed to investigate the effects of CG of intense, competitive sparring following fencing sessions, held at the British Modern Pentathlon training base at the University of Bath.


Description:

The efficacy of compression garments (CG) for recovery will be assessed in 10 elite modern pentathletes, using a crossover design. Athletes will complete each of two different recovery interventions immediately after each of 2 identical 3 hour fencing sessions, in a random order. Sessions will be separated by at least 2 weeks, standardising training in the lead-up to control for training-load and fatigue. A two-way (4 time-points x 2 conditions) crossover trial will be conducted to assess differences in performance tests following fencing ("sparring"), conducted before and after sparring, then 12 hours and 36 hours afterwards. In addition, 3200 m running performance will be assessed the afternoon before and at 12 hours and 36 hours after the fencing session.

All testing will be carried out at the British Modern Pentathlon base at the University of Bath. One month before testing, athletes will familiarised with strength testing using a strain-gauge (MIE Medical Research Ltd., Leeds, UK). Participants will be seated on a plyometric box, starting from a flexed position of 90 degrees, as measured with a goniometer, before taking the best of three attempts of maximal knee flexion. All other measures to be taken form part of the athletes' regular performance monitoring tests. Body composition will be assessed, including height and body-mass, as well as waist, hip thigh, calf, ankle and gluteal circumferences. All limb measurements will be taken from the right side, in accordance with guidelines set by the International Society of Anthropometry and Kinanthropometry (ISAK). Skinfold measurements will be taken according to the ISAK 8 site protocol by a level 1 anthropometrist. Athletes will be fitted for custom fitted (CF) CG (stockings), after taking real-time 3D images using the manufacturer's proprietary, digitised method (Isobar Compression Ltd., Manchester, UK).

In the afternoon before fencing begins (12 midday), 3200 m running performance will be timed using a stopwatch on a 400 m running track (8 laps). Fencing sparring will commence at 5 p.m. the same day, preceded immediately by the other performance measures and physiological tests. Following athletes' individual warm-ups, maximal leg strength will be assessed, as well as vertical jump performance (maximal force and maximum height from the best of 3 attempts) using a force plate (Kistler 3-Component Force-Link, New York, USA). Maximal grip strength will also be assessed (Takei Digital Hand-Grip Dynanometer 4001, Takei Scientific Instruments Co., Niigata-City, Japan). Soreness (200 mm visual analogue scale) and swelling at the mid-thigh skinfold site will also be recorded (spring loaded tape measure - Lafayette Instrument Co, Lafayette, Ind, USA). Muscle damage will be quantified with creatine kinase analysis (CK), and inflammation quantified with C-reactive protein (RX Daytona, Kearneysville, West Virginia, USA) from venous blood samples taken from the arm at baseline and at each time-point throughout recovery. Biomarkers of oxidative damage (the free oxygen radicals - FORT - test) and anti-oxidant defense (free oxygen radicals defense - FORD) will also be assessed. Testing will be conducted after warm-up before sparring, and then immediately after the cessation of the fencing session, after 12 hours and 36 hours recovery. However, 3200 m running performance will be assessed only in the afternoon before, then at 12 hours and 36 hours.

Athletes will complete each of two recovery conditions immediately after training and testing, being randomly assigned to a different condition over each session. Athletes will be allocated to one of the following 3 conditions:

- Custom fitted stockings applying over 30 mmHg and 20 mmHg at the calf and mid-thigh respectively (CF)

- A sham treatment (CON) The CON group will receive a sham "recovery" drink immediately after training (Robinsons no added sugar fruit juice), which contains 1 g carbohydrate and 0 g protein per serving. Pressures at the skin-garment interface will be measured for both garments using a pressure monitor at the medial calf and mid-thigh skinfold sites (as defined by the International Society for Anthropometry and Kinanthropometry), as well as 2 cm above the medial malleolus.

Between-treatment differences in the recovery of performance and physiological factors will be assessed over time using a 2 way (time by condition) mixed-measures analysis of variance (SPSS Statistics 22, IBM, New York, USA).

Equipment used and methods employed make use of validated measures of strength, power, muscle damage and compression pressures, cited in the protocol above.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date February 28, 2019
Est. primary completion date December 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Athletes must be full-time athletes over the age of 18

- Training regularly for at least 3 months without extended disruption to training (> 2 weeks)

Exclusion Criteria:

- Presentation of injuries or chronic illnesses

- Inactivity or disruptions to training > 2 weeks (e.g. due to injury)

- The use of anti-inflammatory medications

- Over 40 years old (classification as a "Masters" athlete)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Compression garments
Made-to-measure compression garments providing high pressures (> 30 mmHg at the ankle and >20 mmHg at the thigh - equivalent to European class-2 stockings)
Other:
Sham recovery drink
Non-caloric beverage, labelled as a "recovery" drink proposed to enhance athletic recovery. Aspartame/acesulfame-k based sweetener, providing 0.5 g carbohydrate and 2 Kcal per serving

Locations

Country Name City State
United Kingdom University of Bath Bath Somerset
United Kingdom St Marys University London

Sponsors (2)

Lead Sponsor Collaborator
St Mary's University College Modern Pentathlon GB

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

Brophy-Williams N, Driller M, Halson S, Fell J, Shing C. Evaluating the Kikuhime pressure monitor for use with sports compression clothing. Sports Engineering. 2014;17(1):55-60

Brown F, Gissane C, Howatson G, van Someren K, Pedlar C, Hill J. Compression Garments and Recovery from Exercise: A Meta-Analysis. Sports Med. 2017 Nov;47(11):2245-2267. doi: 10.1007/s40279-017-0728-9. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal isometric voluntary contraction strength for knee extension (change in Newtons compared to baseline) Participants will be assessed for strength performance with maximal isometric voluntary contraction of the knee extensors (using a strain gauge) at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Primary Lower body reactive strength (jump height/contact time in m/s) following a drop from a 0.6 m box onto a force plate (change in m/s compared to baseline) Participants will be compared to baseline for reactive strength performance at the following time-points after fencing:Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover).
Jump height (m) and contact time (s) will be recorded following a drop from a 0.6 m box onto a force-plate.
36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Primary 3200 m run time trial performance (change in seconds compared to baseline) Participants will be timed for 3200 m running performance at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Secondary Perceived soreness, scored by drawing a vertical line on a 200 mm visual analogue scale from 0 mm (no soreness) to 200 mm (worst soreness imaginable). Change in mm will be compared to baseline. Participants will be measured for muscular soreness at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). Perceived soreness will be scored by drawing a vertical line on a 200 mm visual analogue scale from 0 mm (no soreness) to 200 mm (worst soreness imaginable) and compared to baseline. 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Secondary Circulating creatine kinase concentrations (CK - change in international units compared to baseline) Participants will be measured for circulating creatine kinase concentrations (CK) at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). Change from baseline will be measured in international units (IU) 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Secondary Mid-thigh girth (MTG) at the mid-thigh skinfold site as defined by International Society of Anthropometry and Kinanthropometry. Change will be measured in mm by comparing to baseline Thigh circumference (mm) at the mid-thigh skinfold site (as defined by International Society of Anthropoemtry and Kinanthropometry) will be measured at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Secondary Free oxygen radicals defense (FORD) status (change in mmol/L Trolox equivalents compared to baseline) Blood free oxygen radicals defense (FORD) will be measured from capillary samples taken from the earlobe at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
Secondary Free oxygen radicals (FORT) status (change in mmol/L H2O2 equivalents compared to baseline) Blood free oxygen radicals (FORT) will be measured from capillary samples taken from the earlobe at the following time-points after fencing and compared to baseline: Immediately post, 12 hours post, 36 hours post-fencing (x 2 - crossover). 36 h. Second leg will be conducted after 1 week "washout" (10 days in total)
See also
  Status Clinical Trial Phase
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Unknown status NCT02280668 - Investigating Muscle Repair in Response to Icing Therapy Post Eccentric Muscle Damage Exercise N/A
Recruiting NCT03766815 - Effect of Branched-chain Amino Acid Supplementation on Muscle Damage N/A
Completed NCT04315077 - The Short Term Effects of Oceanix Supplementation on Recovery N/A
Completed NCT03313388 - Tart Cherry Juice for Exercise Performance and Recovery N/A
Completed NCT03753321 - Whey and Soy Protein Supplementation in Football Players N/A
Recruiting NCT06334224 - Acute Physiological Responses to Twice Daily Blood Flow Restriction Training N/A
Completed NCT03707470 - Made to Measure Compression Garments for Recovery in Rugby Players N/A
Completed NCT05037942 - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise N/A
Completed NCT05100459 - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals N/A
Recruiting NCT04549610 - HMB and Exercise-induced Muscle Damage Phase 2/Phase 3
Completed NCT05804604 - Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Completed NCT05011643 - Exercise-induced Muscle Damage in Statin Users
Completed NCT01827696 - Effect of American Ginseng on Exercise-induced Muscle Soreness Phase 1
Completed NCT01728675 - Eccentric Exercise and Oxidative Stress N/A
Completed NCT03527797 - Diaphragm Protective Ventilation in the Intensive Care Unit N/A
Withdrawn NCT05044936 - Topical Cannabidiol Cream and Post-exercise Recovery Early Phase 1
Completed NCT04679519 - The Effects of Protein Supplementation in Females and Males Following Acute Eccentric Exercise N/A
Completed NCT01555775 - Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Recovery After Resistance Exercise N/A